Impact of an intravenous fluconazole restriction policy on patient outcomes

Annals of Pharmacotherapy

Volumn 35, Issue 1, 2001, Pages 9-13

  Burkiewicz, J S ^a   Kostiuk, K A ^a   Jacobs, R A ^a   Guglielmo, B J ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Candidemia; Cost avoidance; Febrile neutropenia; Fluconazole

Indexed keywords

FLUCONAZOLE;

ADOLESCENT; ADULT; ANTIMICROBIAL THERAPY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CHILD; CONTROLLED STUDY; COST CONTROL; FEBRILE NEUTROPENIA; FEMALE; HEALTH CARE COST; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

EID: 0035103414     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.10161     Document Type: Article

References (26)

1. Oral administration of antibiotics: A rational alternative to the parenteral route
2. Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia
3. Clinical and economic evaluation of oral ciprofloxacin after an abbreviated course of intravenous antibiotics
4. Early switch from intravenous to oral antibiotics in hospitalized patients with infections: A 6-month prospective study
5. Oral ofloxacin for the treatment of acute bacterial pneumonia: Use of a nontraditional protocol to compare experimental therapy with "usual care" in a multicenter clinical trial
6. Clinical and economic impact of oral ciprofloxacin as follow-up to parenteral antibiotics
7. Influence of concomitant food intake on the oral absorption of two triazole antifungal agents, itraconazole and fluconazole
8. The influence of gastric pH on the pharmacokinetics of fluconazole: The effect of omeprazole
9. Pharmacokinetics and bioavailability of fluconazole in two groups of males with human immunodeficiency virus (HIV) infection compared with those in a group of males without HIV infection
10. Bioavailability of fluconazole administered via a feeding tube in intensive care unit patients
11. Bioavailability of fluconazole in surgical intensive care unit patients: A study comparing routes of administration
12. Oropharyngeal and esophageal candidiasis in immuno-compromised patients: Treatment issues
13. Oral fluconazole for Candida urinary tract infection
14. Antifungal prophylaxis during neutropenia and immunodeficiency
15. Randomized trial of fluconazole versus nystatin for the prophylaxis of Candida infection following liver transplantation
16. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection
17. A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation
18. Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplant - A prospective, randomized, double-blind study
19. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia
20. Randomized, double-blind clinical trial of amphotericin B colloidal dispersion vs. amphotericin B in the empirical treatment of fever and neutropenia
21. Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients
22. Management of invasive candidal infections: Results of a prospective, randomized, multicenter study of fluconazole versus amphotericin B and review of the literature
23. Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: A matched cohort study
24. The total process cost of parenteral antibiotic therapy: Beyond drug acquisition cost